Japan Strengthens Regenerative Medicine Oversight.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29395052.
- Also identified by DOI 10.1016/j.stem.2018.01.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.
Medical subject headings
- Regenerative Medicine